AzTrials
AzTrials

DepressionNCT04237714

Internet-based Intervention Culturally Adapted for Treatment of Depression in the Ecuadorian Population

A study testing Smiling is fun in people with Depression, run by University of Valencia at 1 site in Ecuador.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Internet-Based Interventions are increasingly relevant as an alternative for reducing the gap in treatment of metal disorders such as depression, especially in resource-limited regions. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Depression
What is being tested?
Smiling is fun
Could I receive a placebo?
No, everyone receives an active treatment
How many people
153 participants
Where
1 siteEcuador
Study dates
10 Oct 2020to Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Ability to understand and read Spanish and access to Internet and having an email address
  • Access to a computer or smart phone with internet at home
  • Criteria for diagnosis of depression disorder according to the MINI interview and score between 5 to 9 (mild) 10 to 14 (moderate) and 15 to 19 (Moderate/severe) on PHQ-9

Who cannot join

  • Scores 20-27 (severe depression) on PHQ-9
  • Suicidal risk
  • Severe psychiatric disorders (schizophrenia, substance dependence, bipolar disorder, psychotic illness)
  • Receiving psychological treatment for depression at the time of recruitment

Trial locations and contacts

1 site in 1 country.

Carlos E Quiñonez, MSc contact

+593 999277152

carequi@alumni.uv.es

Ecuador1 site, 1 recruiting
  • Carlos Quiñonez Freire

    Santo Domingo, 230108

    Carlos Quiñonez Freire, MSc, +593 999277152, carequi@alumni.uv.es

    Recruiting

Other trials in Ecuador

About this study

Official title: Cultural Adaptation of the Smile is Fun Program for the Treatment of Depression in the Ecuadorian Public Health Care System: A Study Protocol for a Randomized Controlled Trial

Internet-Based Interventions are increasingly relevant as an alternative for reducing the gap in treatment of metal disorders such as depression, especially in resource-limited regions.

In this study the investigators will try to evaluate the effectiveness of an Internet-Based Intervention culturally adapted to the Ecuadorian population for treatment of depression.

Read the detailed description

Our participants will be randomized to one of the following three conditions: 1) Internet-Based intervention (IBI) with automated support (e.g. e-mails or text messages), 2) IBI plus human support by phone calls (automated + human support), 3) Waiting list control group .

The corresponding evaluations of the outcomes will be carried out at different moments of the process: baseline, three, six and twelve months.

This study will use the Smile is Fun program for the treatment of depression previously adapted to the Ecuadorian context.

Conditions
Depression
Being tested
Smiling is fun
Keywords
Cultural adaptation, Internet-based intervention, Depression
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Smiling is funBehavioural

    Smile is Fun is a self-applied program that combines elements of prevention and psychological treatment for emotional disorders. It is delivered via the Internet and it is based on CBT technics. The program consists of 8 therapeutic modules and includes 3 transversal tools (activity report, calendar, how am I?) to provide feedback and accompany patients during the intervention. The program requires 8 to 10 weeks to complete in its entirety.

    The intervention, initially developed in Spain, will be adapted to the Ecuadorian culture including elements of the local population, such as, dialect, personal stories, examples and activities. The Ecuadorian version will be evaluate by health professional and users of public health system of Ecuador.

Study groups in NCT04237714
Study groupRoleWhat they receive
IBI-based automated supportExperimentalInternet-based intervention with automated support by the system. It consistes in phone text messages twice a week for users. The content of the messages focuses on motivating and reminding users to complete the activities proposed in the program and reviewing the treatment contents. Additionally an automatic email is send if participants have not access the program for a week. The program also provides continuous feedback to users through transversal tools.
Receives: Behavioral: Smiling is fun
IBI-plus human supportExperimentalIn this condition, the participants receive automated support explained above and additionally human support for a maximum of 5 minutes that consist in a weekly phone call provided by a psychologist. The content of phone calls is related with resolve questions or doubts about the use and clinical content of the IBI and also motivating and reminding the importance to complete activities in the program.
Receives: Behavioral: Smiling is fun
Control groupNo interventionWaiting list control group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in depression symptoms. Beck Depression Inventory- II (BDI-II)

    It is a 21 item self-report that measure the presence of depressive symptoms in the past two weeks. Spanish version by Sanz et al., 2003.

    Measured: Baseline (week 0), 3, 6 and 12 months.

  2. Change in depression symptoms. Patient Health Questionnaire (PHQ-9)

    The questionnaire is composed of 9 items, it can be used as a screening test or as an evaluation instrument for depressive disorder. Spanish version by Diez-Quevedo et al., 2001.

    Measured: Baseline (week 0), 3, 6 and 12 months.

Secondary outcomes (13)
  1. Generalized Anxiety Disorder Scale (GAD-7)

    It is a 7-item scale designed for symptom detection and severity analysis of generalized anxiety disorder. Spanish version by Muñoz-Navarro et al., 2017.

    Measured: Baseline (week 0), 3, 6 and 12 months.

  2. Positive and Negative Affect Schedule (PANAS)

    This scale consists of 2 subscales, each with 10 items that value positive and negative affects. Spanish version by Lopez-Gomez, Hervas, \& Vazquez, 2015.

    Measured: Baseline (week 0), post-module (weekly for 8 weeks), 3, 6 and 12 months.

  3. Overall Anxiety Severity and Impairment Scale (OASIS)

    This scale has five items related with: the frequency of symptoms of anxiety, their intensity, their interference with the person's work or school life, and their interference with social life. All items are rated on a 5-point Likert scale ranging from 0 (I didn't feel anxious) to 4 (Constant anxiety). Spanish version by Osma, J et al. 2019

    Measured: post-module (weekly for 8 weeks)

  4. Overall Depression Severity and Impairment Scale ODSIS

    The ODSIS includes five items related with: the frequency of symptoms of depression, their intensity, their interference with the person's work or school life, and their interference with social life. All items are rated on a 5-point Likert scale ranging from 0 (I didn't feel depression) to 4 (Constant depression).

    Measured: post-module (weekly for 8 weeks)

  5. Assessment of Quality of life (AQoL-6D)

    It is a 20-item questionnaire that measures the following dimensions of the patient's health status: illness, independence to live, social relationships, physical and psychological well-being.

    Measured: Baseline (week 0), 3, 6 and 12 months

  6. Trimbos/iMTA Questionnaire on costs on Psychiatric Illnesses (TIC-P)

    Questionnaire used to collect information on health services and medication received during the last months, as well as, information on productivity loss in paid and unpaid work depending on the illness.

    Measured: Baseline (week 0), 3, 6 and 12 months.

  7. Client Satisfaction Questionnaire (CSQ-8)

    This is a 8-item questionnaire that measures the perception of the attention received. Spanish version by Echeburúa \& Corral, 1998

    Measured: 3 months

  8. Attitudes Towards Psychological Interventions (APOI)

    The questionnaire measures expectations towards online psychological interventions. Its 16 items measure: a) skepticism and risk perception, b) confidence in effectiveness, c) risks of technology and d) anonymous benefits.

    Measured: Baseline (week 0)

  9. Credibility and Expectancy Questionnaire (CEQ)

    This scale is a self-administered 6-item assessment instrument created to measure the belief that the treatment works and the expectations that the treatment will improve.

    Measured: Baseline (week 0)

  10. Semi-structured qualitative interview

    An Ad-hoc instrument with open questions created to investigate the reasons for abandoning treatment.

    Measured: post-treatment (8 weeks)

  11. Working Alliance Inventory for Online Intervention-Short Form (WAI-TECH- SF)

    It is a 12-item self-report adapted of the WAI-SF (Hatcher and Gillaspy, 2006). This questionnaire aimed at assessing the working alliance with the online intervention.

    Measured: Baseline (week 0)

  12. System Usability Scale (SUS)

    The SUS is a 10-item self-report scale from 0 ("strongly disagree") to 4 ("strongly agree") that measures the usability of a service or product and the acceptance of technology by people who use it.

    Measured: 3 months

  13. Semi-structured qualitative interview

    A 11-item qualitative interview will be developed. It consists of 6 items rated on a scale from 1 ("very little") to 5 ("very much") and 4 dichotomous questions ("yes" or "no") to assess participants' opinions about the program and the support received.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2020
  2. Study start10 Oct 2020
  3. Primary completionDec 2021 (estimated)
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
153 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04237714
Sponsor's protocol ID
00016-UV-E-2019
Status last verified
May 2021
First submitted
15 Jan 2020
Last updated
2 Jun 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Andersson G, Carlbring P, Titov N, Lindefors N. Internet Interventions for Adults with Anxiety and Mood Disorders: A Narrative Umbrella Review of Recent Meta-Analyses. Can J Psychiatry. 2019 Jul;64(7):465-470. doi: 10.1177/0706743719839381. Epub 2019 May 16.

    PubMed 31096757
  • Andersson G, Cuijpers P, Carlbring P, Riper H, Hedman E. Guided Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta-analysis. World Psychiatry. 2014 Oct;13(3):288-95. doi: 10.1002/wps.20151.

    PubMed 25273302
  • Berger T, Hammerli K, Gubser N, Andersson G, Caspar F. Internet-based treatment of depression: a randomized controlled trial comparing guided with unguided self-help. Cogn Behav Ther. 2011;40(4):251-66. doi: 10.1080/16506073.2011.616531.

    PubMed 22060248
  • Cuijpers P, van Straten A, Andersson G, van Oppen P. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol. 2008 Dec;76(6):909-22. doi: 10.1037/a0013075.

    PubMed 19045960
  • Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86. doi: 10.1016/s0005-7916(00)00012-4.

    PubMed 11132119
  • Espinosa HD, Carrasco A, Moessner M, Caceres C, Gloger S, Rojas G, Perez JC, Vanegas J, Bauer S, Krause M. Acceptability Study of "Ascenso": An Online Program for Monitoring and Supporting Patients with Depression in Chile. Telemed J E Health. 2016 Jul;22(7):577-83. doi: 10.1089/tmj.2015.0124. Epub 2016 Jan 7.

    PubMed 26741190
  • Hadjistavropoulos HD, Nugent MM, Alberts NM, Staples L, Dear BF, Titov N. Transdiagnostic Internet-delivered cognitive behaviour therapy in Canada: An open trial comparing results of a specialized online clinic and nonspecialized community clinics. J Anxiety Disord. 2016 Aug;42:19-29. doi: 10.1016/j.janxdis.2016.05.006. Epub 2016 May 13.

    PubMed 27244278
  • Harper Shehadeh M, Heim E, Chowdhary N, Maercker A, Albanese E. Cultural Adaptation of Minimally Guided Interventions for Common Mental Disorders: A Systematic Review and Meta-Analysis. JMIR Ment Health. 2016 Sep 26;3(3):e44. doi: 10.2196/mental.5776.

    PubMed 27670598
  • Bouwmans C, De Jong K, Timman R, Zijlstra-Vlasveld M, Van der Feltz-Cornelis C, Tan Swan S, Hakkaart-van Roijen L. Feasibility, reliability and validity of a questionnaire on healthcare consumption and productivity loss in patients with a psychiatric disorder (TiC-P). BMC Health Serv Res. 2013 Jun 15;13:217. doi: 10.1186/1472-6963-13-217.

    PubMed 23768141
  • Hawthorne G, Richardson J, Osborne R. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res. 1999 May;8(3):209-24. doi: 10.1023/a:1008815005736.

    PubMed 10472152
  • Helms JE. An examination of the evidence in culturally adapted evidence-based or empirically supported interventions. Transcult Psychiatry. 2015 Apr;52(2):174-97. doi: 10.1177/1363461514563642. Epub 2014 Dec 22.

    PubMed 25534401
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

    PubMed 11556941
  • Lara MA, Tiburcio M, Aguilar Abrego A, Sanchez-Solis A. A four-year experience with a Web-based self-help intervention for depressive symptoms in Mexico. Rev Panam Salud Publica. 2014 May-Jun;35(5-6):399-406.

    PubMed 25211568
  • Mira A, Breton-Lopez J, Garcia-Palacios A, Quero S, Banos RM, Botella C. An Internet-based program for depressive symptoms using human and automated support: a randomized controlled trial. Neuropsychiatr Dis Treat. 2017 Mar 31;13:987-1006. doi: 10.2147/NDT.S130994. eCollection 2017.

    PubMed 28408833
  • Munoz-Navarro R, Cano-Vindel A, Moriana JA, Medrano LA, Ruiz-Rodriguez P, Aguero-Gento L, Rodriguez-Enriquez M, Piza MR, Ramirez-Manent JI. Screening for generalized anxiety disorder in Spanish primary care centers with the GAD-7. Psychiatry Res. 2017 Oct;256:312-317. doi: 10.1016/j.psychres.2017.06.023. Epub 2017 Jun 12.

    PubMed 28666201

Questions about this trial

What is this clinical trial studying?

A study testing Smiling is fun in people with Depression, run by University of Valencia at 1 site in Ecuador.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ecuador. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Carlos E Quiñonez, MSc (+593 999277152, carequi@alumni.uv.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in depression symptoms. Beck Depression Inventory- II (BDI-II) (time frame: Baseline (week 0), 3, 6 and 12 months.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04237714, which also lists 26 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in